Cercar
16/08/2023
Lights and shadows of the 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Martín-Rioboó E, Brotons-Cuixart C, Ruiz García A, Villafañe Sanz F, Frías Vargas M, Moyá Amengual A, Divisón Garrote JA, Seoane Vicente MC, Banegas JR, Pallarés Carratalá V. Lights and shadows of the 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.. Revista Espanola de Salud Publica. 2023; 97DOI:. PMID:37921403. IF:(Q/D).
01/08/2023
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Zhou, XD, Targher, G, Byrne, CD, Somers, V, Kim, SU, Chahal, CAA, Wong, VWS, Cai, JJ, Shapiro, MD, Eslam, M, Steg, PG, Sung, KC, Misra, A, Li, JJ, Brotons, C, Huang, YL, Papatheodoridis, GV, Sun, AJ, Yilmaz, Y, Chan, WK, Huang, H, Mendez-Sanchez, N, Alqahtani, SA, Cortez-Pinto, H, Lip, GYH, de Knegt, RJ, Ocama, P, Romero-Gomez, M, Fudim, M, Sebastiani, G, Son, JW, Ryan, JD, Ikonomidis, I, Treeprasertsuk, S, Pastori, D, Lupsor-Platon, M, Tilg, H, Ghazinyan, H, Boursier, J, Hamaguchi, M, Nguyen, MH, Fan, JG, Goh, GBB, Al Mahtab, M, Hamid, S, Perera, N, George, J, Zheng, MH. An international multidisciplinary consensus statement on MAFLD and the risk of CVD. Hepatology International. 2023; 17(4)DOI:10.1007/s12072-023-10543-8. PMID:37204656. IF:5.900(Q1/2D).
19/07/2023
Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial
Guan, YF, Puenpatom, A, Johnson, MG, Zhang, Y, Zhao, YJ, Surber, J, Weinberg, A, Brotons, C, Kozlov, R, Lopez, R, Coetzee, K, Santiaguel, J, Du, JJ, Williams-Diaz, A, Brown, M, Paschke, A, De Anda, C, Norquist, JM. Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial. CLINICAL INFECTIOUS DISEASES. 2023; 77(11)DOI:10.1093/cid/ciad409. PMID:37466374. IF:8.200(Q1/1D).
01/06/2023
Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe)
Herrera, D, Sanz, M, Shapira, L, Brotons, C, Chapple, I, Frese, T, Graziani, F, Hobbs, FDR, Huck, O, Hummers, E, Jepsen, S, Kravtchenko, O, Madianos, P, Molina, A, Ungan, M, Vilaseca, J, Windak, A, Vinker, S. Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe). JOURNAL OF CLINICAL PERIODONTOLOGY. 2023; 50(6)DOI:10.1111/jcpe.13807. PMID:36935200. IF:5.800(Q1/1D).